A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy
Conditions: Epilepsy
Principal Investigator: Matt Lallas
CRA: Marinellie Vega
Learn more at https://clinicaltrials.gov/study/NCT05323734.
A Multicenter, Open-Labe, Randomized, Active Comparator Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates with Repeated Electroencephalographic Neonatal Seizures
Conditions: Epilepsy
Principal Investigator: Anuj Jayakar
CRA: Marinellie Vega
A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous Ganaxolone in status epilepticus Ganaxolone
Conditions: Epilepsy
Principal Investigator: Anuj Jayakar
CRA: Marinellie Vega
Learn more at https://clinicaltrials.gov/study/NCT04391569.
A Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study with a 2-Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age with Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Conditions: Epilepsy
Principal Investigator: Anuj Jayakar
CRA: Marinellie Vega
Learn more at https://clinicaltrials.gov/study/NCT04666610.
Predicting Seizure Responsiveness to Neuromodulation Using Connectomic Profiling (Vagus Nerve Stimulation [VNS] Study)
Conditions: Epilepsy
Principal Investigator: Shelly Wang
CRA: Marinellie Vega